Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2005
10/05/2005EP1582211A1 Jnk inhibitor
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1582209A1 The use of succinate derivative esters for the treatment of dementia
10/05/2005EP1581759A2 Methods for treating taxol-induced sensory neuropathy
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581538A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity
10/05/2005EP1581532A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
10/05/2005EP1581525A2 Compounds having an activity at metabotropic glutamate receptors
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581492A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2005EP1581490A1 Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
10/05/2005EP1581472A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
10/05/2005EP1581249A2 Methods of treating neurological conditions with hematopoeitic growth factors
10/05/2005EP1581235A1 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia
10/05/2005EP1581234A2 Methods for treating migraine
10/05/2005EP1581230A2 Method and compositions for treating anxiety
10/05/2005EP1581225A1 Combination therapy for the treatment of pain
10/05/2005EP1581221A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
10/05/2005EP1581219A1 Treatment of psychostimulant addiction
10/05/2005EP1581214A1 4,5-diarylthiazole derivatives as cb-1 ligands
10/05/2005EP1581203A1 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/05/2005EP1581163A2 Use of istradefylline (kw-6002) for the treatment of behavioral disorders
10/05/2005EP1419154B1 Rapamycin 29-enols
10/05/2005EP1385536B1 Preparations containing a combination of vitamin e and afamin
10/05/2005EP1370271B1 A process for the manufacture of a herbal composition comprising a matrine
10/05/2005EP1368007B1 Coating and binding agent for pharmaceutical formulations with improved storage stability
10/05/2005EP1325008B1 Piperazine derivatives
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1257280B1 Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy
10/05/2005EP1230217B1 Positive modulators of nicotinic receptor agonists
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1094804B1 The treatment of renal colic with gaba analogs
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678626A Estrieno[3, 2-b]/[3, 4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/05/2005CN1678615A Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/05/2005CN1678614A Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/05/2005CN1678611A Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
10/05/2005CN1678610A New quinuclidine amide derivatives
10/05/2005CN1678609A 2-pyrrolidin-2-yl-[1, 3, 4]-oxadiazole derivatives and their use as anti-depressants
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678352A Adhesive patch
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678325A Sapogenin derivatives, their synthesis and use and method based upon the use
10/05/2005CN1678322A New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2, 3-D]pyrimidine
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678316A Piperidin-2, 6-dione pamoate salts and their use for the treatment of stress-related affective disorders
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678304A PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
10/05/2005CN1678298A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
10/05/2005CN1678290A Dosage forms for increasing the solubility of slow releas drugs
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676138A Chinese medicine for treating headache
10/05/2005CN1676129A Use of benzy hydrobromide tropine for preparing medicine for treating epilepsia
10/05/2005CN1676121A Slow-release micro-ball formulation for tissue, organ local therapy, and its preparing method and use
10/05/2005CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes
10/05/2005CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/05/2005CN1221550C Crgstalline form II of cabergoline
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221278C 'Naoan' preparation for curing apoplexy and migraine and producing method
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221257C Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treatment of neurogenic inflammation
10/05/2005CN1221255C New use of sulpiride in pharmacy
10/05/2005CN1221254C New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951938 Aryl fused azapolycyclic compounds
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951890 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951885 Pharmaceutical composition
10/04/2005US6951884 Fluorobenzamides and uses thereof
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951875 Conjugated aromatic compounds with a pyridine substituent
10/04/2005US6951874 Compounds
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951870 Ortho-diihydroxy- coumarin or 1,2--dihydroquinoline derivatives as catechol-O-methyltransferase enzyme inhibitors for Parkinson*s disease treatment
10/04/2005US6951868 Central nervous system disorders, gastrointestinal disorders;side effect reduction
10/04/2005US6951864 4-imidazol-1-ylmethyl-pyrimidine derivatives
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005US6951861 Chemical compounds
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951854 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
1 ... 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 ... 1833